Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
177,455,640
-
Shares change
-
+3,593,043
-
Total reported value, excl. options
-
$2,362,005,410
-
Value change
-
+$49,445,414
-
Put/Call ratio
-
18%
-
Number of buys
-
92
-
Number of sells
-
-77
-
Price
-
$13.31
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q4 2019
213 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q4 2019.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177,455,640 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (21,723,672 shares), BROWN CAPITAL MANAGEMENT LLC (17,901,053 shares), VANGUARD GROUP INC (16,638,941 shares), BlackRock Inc. (13,541,545 shares), FMR LLC (10,804,989 shares), Sarissa Capital Management LP (10,307,000 shares), UBS ASSET MANAGEMENT AMERICAS INC (8,744,233 shares), JANUS HENDERSON GROUP PLC (8,289,895 shares), MFN Partners Management, LP (6,439,541 shares), and STATE STREET CORP (5,774,445 shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.